NCT00460590View on ClinicalTrials.gov

Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Tuberculosis
Interventions
BIOLOGICAL

MVA 85A

ID vaccine

Trial Locations (1)

7925

University Cape Town, Cape Town

All Listed Sponsors
collaborator

University of Cape Town

OTHER

lead

University of Oxford

OTHER

NCT00460590 - Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town | Biotech Hunter | Biotech Hunter